Warning
PAYLESS COMPOUNDERS Recalls Semaglutide-Glycine-Cyanocobalamin Injectable
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0471-2026Drug / Pharmaceutical
PAYLESS COMPOUNDERS Recalls Semaglutide-Glycine-Cyanocobalamin Injectable
PAYLESS COMPOUNDERS, LLC · Class II — Moderate Risk
Product Description
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Reason for Recall
Lack of Assurance of Sterility
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
OR
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
Sources: FDA openFDA Enforcement Database